// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























7277 Abstracts

Efficacy and Safety of Rivaroxaban Compared with Warfarin Among Elderly Patients with Nonvalvular Atrial Fibrillation in the ROCKET-AF Trial

Graeme J Hankey - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

rivaroxaban

Increased Risk of Venous Thromboembolism Associated with use of Non Steroidal Anti-Inflammatory Drugs among Patients with Prior Myocardial Infarction - A Nationwide Cohort Study

Emil L. Fosbol - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Diclofenac

Severe Left Ventricle Systolic Dysfunction is an Independent Predictor of Poor Response to Clopidogrel

Martina Ondrakova - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Clopidogrel bisulfate

Bare Metal Stents, Durable Polymer Drug Eluting Stents or Biodegradable Polymer Stents for Coronary Artery Disease: A Mixed Treatment Comparison Analysis of 254 361 Patient-Years of Follow-up From Randomized Trials

Nicholas Amoroso - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Clinical Value of Angiotensin-converting Enzyme Inhibitor and Angiotensin Receptor Blocker in the Patients of Coronary Artery Disease

Akira Sato - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Angiotensin II

Altered Natural Killer Cell Subsets, Phenotype and Activity in Adamts13-deficient TTP Patients With a History of Relapse

Christina Lawrence - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

lonomycin

Evidence That Links Cyclo-oxygenase-2 Inhibition With Increased Asymmetric Dimethylarginine: Novel Explanation of Cardiovascular Side Effects Associated With Anti-inflammatory Drugs

Nicholas S Kirkby - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Prostacyclin

Assessment of Neointimal Tissue Characterization after Bare Metal Stent Implantation: Integrated Backscatter Ultrasound Study

Hideki Ishii - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Morphine Delays the Onset of Action of Prasugrel in Patients With Prior History of St Elevation Myocardial Infarction

Rashed Hossain - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Prasugrel

Bleeding Likelihood of Apixaban in Primary VTE Prophylaxis: A Meta-Analysis

Harsh Golwala - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Enoxaparin

A Novel MPO Inhibitor, PF-1355, Significantly Attenuates Disease Activity in Immune Complex Vasculitis and Glomerulonephritis Mouse Models

Wei Zheng - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Remote Ischemic Preconditioning reduces Thrombus Formation in the Rat

Vibeke E Hjortdal - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Clinical Impact of Integrated Backscatter Intravascular Ultrasound Analysis for Predicting Major Adverse Cardiac Events After Primary Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome

Hiroki Takahashi - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Intraluminal and Intrawall Hyperintense Plaques Identified by Noncontrast T1-Weighted Magnetic Resonance Imaging Showed Different Vulnerable Plaque Morphology Assessed by Optical Coherence Tomography

Shoichi Ehara - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Differences in Neointimal Coverage Among Bare-Metal Stent and 3 Types of Second-Generation Drug-Eluting Stents at 9 Months After Implantation Using Optical Coherence Tomography in Patients With ST-Segment Elevation Myocardial Infarction

Shiro Hata - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

Thrombin-inhibiting Liposomes for Safe, Site-specific Inhibition of Acute Thrombosis

Jacob W Myerson - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Evithrom

Noninvasive Diagnosis of Ventricular Assist Device Thrombosis Using Fibrin-Specific Nuclear Imaging

Walter Akers - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Rose bengal sodium

Pulmonary Embolism Outcomes After Discharge From the Emergency Department: The CVRN VTE Study

Dongjie Fan - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

The Association of Warfarin Control With Pulmonary Embolism Mortality: The CVRN VTE Study

Dongjie Fan - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Warfarin

Optimal Antithrombotic Therapy After Coronary Artery Bypass Surgery: More is Not Better!

Dana Villines - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Clopidogrel bisulfate

Copyright © 2026. QuantiNova All rights reserved